Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
RESEARCH TOOLSreports
Holding GPCR?
Track your performance easily
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview
15.35% Insiders
38.23% Mutual Funds
0.49% Other Institutional Investors
1.12% ETFs
44.81% Public Companies and Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 39.84% of the company’s stock is owned by Institutional Investors, 15.35% is owned by Insiders, and 44.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 05, 2024 | Xichen Lin Cso | xxxxxxxxxxxxx | $5600988 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $20695 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $144709 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1368638 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1480479 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,249,936 | Institution | 7.43% | 164,472,523 | |
| 4,040,713 | Institution | 7.06% | 156,375,593 | |
| 2,859,826 | Insider | 5.00% | 110,675,266 | |
| 2,677,719 | Insider | 4.68% | 103,627,725 | |
| 2,577,136 | Institution | 4.51% | 99,735,163 | |
| 2,377,300 | Institution | 4.16% | 92,001,510 | |
| 2,347,932 | Insider | 4.11% | 90,864,968 | |
| 1,896,772 | Institution | 3.32% | 73,405,076 | |
| 1,450,003 | Institution | 2.54% | 56,115,116 | |
| 1,122,362 | Institution | 1.96% | 43,435,409 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,249,936 | Institution | 7.43% | 164,472,523 | |
| 4,040,713 | Institution | 7.06% | 156,375,593 | |
| 2,377,300 | Institution | 4.16% | 92,001,510 | |
| 1,450,003 | Institution | 2.54% | 56,115,116 | |
| 1,122,362 | Institution | 1.96% | 43,435,409 | |
| 1,116,078 | Institution | 1.95% | 43,192,219 | |
| 983,176 | Institution | 1.72% | 38,048,911 | |
| 727,269 | Institution | 1.27% | 28,145,310 | |
| 642,925 | Institution | 1.12% | 24,881,198 | |
| 602,158 | Institution | 1.05% | 23,303,515 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 327,744 | Institution | 0.57% | 12,683,693 | |
| 47,590 | Institution | 0.08% | 1,809,372 | |
| 40,710 | Institution | 0.07% | 1,786,762 | |
| 43,588 | Institution | 0.08% | 1,657,216 | |
| 43,529 | Institution | 0.08% | 1,654,973 | |
| 33,595 | Institution | 0.06% | 1,277,282 | |
| 15,953 | Institution | 0.03% | 700,177 | |
| 13,248 | Institution | 0.02% | 512,698 | |
| 8,137 | Institution | 0.01% | 309,369 | |
| 7,277 | Institution | 0.01% | 276,672 |
FAQ
Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 0.49% of the company's stock is held by institutional investors, 15.35% is held by insiders, and 44.81% is held by retail investors.
What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.49% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.81% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
SMALLCAP World Fund Inc owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.